Literature DB >> 8333984

A reversible form of apical left ventricular hypertrophy associated with pheochromocytoma.

E R Schuiki1, R Jenni, F W Amann, W H Ziegler.   

Abstract

A patient with pheochromocytoma was found to have typical features of apical left ventricular hypertrophy similar to apical hypertrophic cardiomyopathy of the Japanese type. The electrocardiogram showed giant negative T waves (1.0 mV), and echocardiography as well as angiographic examination revealed left ventricular hypertrophy confined to the apex. Surgical removal of the tumor resulted in striking regression of apical hypertrophy and essential normalization of the electrocardiogram within 1 year of operation. These findings emphasize the possible role of catecholamines in the cause of apical hypertrophic cardiomyopathy and illustrate the potential reversibility of this condition in association with pheochromocytoma. It is suggested that patients with signs of apical left ventricular hypertrophy should undergo thorough screening for a pheochromocytoma.

Entities:  

Mesh:

Year:  1993        PMID: 8333984     DOI: 10.1016/s0894-7317(14)80072-2

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  3 in total

1.  Prevalence and patterns of left ventricular dysfunction in patients with pheochromocytoma.

Authors:  Jae-Hyeong Park; Kyu Seop Kim; Ji-Young Sul; Sung Kyun Shin; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2011-06-30

2.  Pheochromocytoma: an endocrine stress mimicking disorder.

Authors:  Vitaly Kantorovich; Graeme Eisenhofer; Karel Pacak
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

3.  Encapsulated pheochromocytoma cells secrete potent noncatecholamine factors.

Authors:  Hector R Mobine; George C Engelmayr; Nelson Moussazadeh; Tayyba R Anwar; Lisa E Freed; Elazer R Edelman
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.